About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: June 2011
Social Media Guidance with a British Accent
While FDA’s Division of Drug Marketing, Advertising and Communication does what it does with respect to developing some regulatory policy on the Internet over the course of many years, in Britain with new guidance on pharmacovigilance due in 2012, the … Continue reading
Posted in FDA Policy, New and Social Media
2 Comments
Weekly Roundup – 6-24/11
Summer officially began. The days have, by seconds only, begun to grow shorter. Storms threaten on a nearly daily basis. Humidity is a constant companion. And today was the last day of school in my neighborhood making me happy once … Continue reading
Posted in Uncategorized
Comments Off on Weekly Roundup – 6-24/11
FDA’s Social Media Assets – Twitter Overview
Yesterday PharmExec.com carried a quote from the Division of Drug Marketing, Advertising and Communications (DDMAC) that the division’s highest priority is the issuance of a social media guideline. But for some time now, while not offering any guidance for industry … Continue reading
Posted in FDA Image, New and Social Media
1 Comment
FDA Goes Graphic on New Cigarette Labeling
Last November the FDA announced an intention to up the ante when it comes to labeling for the packages of cigarettes and put on display for our consideration several versions of labels that offered quite graphic warnings on the dangers … Continue reading
Posted in Uncategorized
2 Comments
FDA Launches Initiative Aimed at Imports
There is no question for even the most casual observer that the exploding globalization movement of the 1990s has led to expansive imports during the decade I like to call the Uh-ohs (2000s). Globalization has brought with it many benefits. … Continue reading
Posted in FDA Policy, Food, Safety and Risk Issues
Tagged Safety and Risk Issues
Comments Off on FDA Launches Initiative Aimed at Imports